Abbink EJ - Search Results

1

High Diabetes Distress Among Ethnic Minorities Is Not Explained by Metabolic, Cardiovascular, or Lifestyle Factors: Findings From the Dutch Diabetes Pearl Cohort.

Özcan B, Rutters F, Snoek FJ, Roosendaal M, Sijbrands EJ, Elders PJM, Holleman F, Pijl H, Tack CJ, Abbink EJ, de Valk HW, Wolffenbuttel BHR, Stehouwer CDA, Schaper NC, Dekker JM, Schram MT; Diabetes Pearl from the Parelsnoer Initiative. Özcan B, et al. Among authors: abbink ej. Diabetes Care. 2018 Sep;41(9):1854-1861. doi: 10.2337/dc17-2181. Epub 2018 Jun 26. Diabetes Care. 2018. PMID: 29945936

2

Vascular effects of metabolic inhibition by 2-deoxy-D-glucose in humans.

Abbink EJ, Tack CJ, Smits P. Abbink EJ, et al. J Cardiovasc Pharmacol. 2001 Jan;37(1):94-100. doi: 10.1097/00005344-200101000-00011. J Cardiovasc Pharmacol. 2001. PMID: 11152379

3

Vascular K(ATP) channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetes.

Abbink EJ, Pickkers P, van Rosendaal AJ, Lutterman JA, Tack CJ, Russel FG, Smits P. Abbink EJ, et al. Clin Sci (Lond). 2002 Mar;102(3):307-14. Clin Sci (Lond). 2002. PMID: 11869171

4

Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients.

Abbink EJ, Pickkers P, Jansen van Rosendaal A, Lutterman JA, Tack CJ, Russel FG, Smits P. Abbink EJ, et al. Diabet Med. 2002 Feb;19(2):136-43. doi: 10.1046/j.1464-5491.2002.00663.x. Diabet Med. 2002. PMID: 11874430 Clinical Trial.

5

No role of calcium- and ATP-dependent potassium channels in insulin-induced vasodilation in humans in vivo.

Abbink EJ, Walker AJ, van der Sluijs HA, Tack CJ, Smits P. Abbink EJ, et al. Diabetes Metab Res Rev. 2002 Mar-Apr;18(2):143-8. doi: 10.1002/dmrr.269. Diabetes Metab Res Rev. 2002. PMID: 11994906

6

Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation.

Abbink EJ, van der Wal PS, Sweep CG, Smits P, Tack CJ. Abbink EJ, et al. Diabetes Metab Res Rev. 2004 Nov-Dec;20(6):466-71. doi: 10.1002/dmrr.474. Diabetes Metab Res Rev. 2004. PMID: 15386823 Clinical Trial.

7

Effect of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidaemia.

ter Avest E, Abbink EJ, de Graaf J, Tack CJ, Stalenhoef AF. ter Avest E, et al. Among authors: abbink ej. Eur J Clin Invest. 2005 Sep;35(9):558-64. doi: 10.1111/j.1365-2362.2005.01549.x. Eur J Clin Invest. 2005. PMID: 16128862 Clinical Trial.

8

Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH).

ter Avest E, Abbink EJ, Holewijn S, de Graaf J, Tack CJ, Stalenhoef AF. ter Avest E, et al. Among authors: abbink ej. Curr Med Res Opin. 2005 Sep;21(9):1469-76. doi: 10.1185/030079905X61910. Curr Med Res Opin. 2005. PMID: 16197666 Clinical Trial.

9

Effects of pioglitazone in familial combined hyperlipidaemia.

Abbink EJ, De Graaf J, De Haan JH, Heerschap A, Stalenhoef AF, Tack CJ. Abbink EJ, et al. J Intern Med. 2006 Jan;259(1):107-16. doi: 10.1111/j.1365-2796.2005.01579.x. J Intern Med. 2006. PMID: 16336518 Free article. Clinical Trial.

10

Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology.

Engwerda EE, Abbink EJ, Tack CJ, de Galan BE. Engwerda EE, et al. Among authors: abbink ej. Diabetes Care. 2011 Aug;34(8):1804-8. doi: 10.2337/dc11-0182. Epub 2011 Jun 29. Diabetes Care. 2011. PMID: 21715522 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters